Penumbra Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. The Neuro division specializes in providing advanced solutions for neurovascular conditions, including stroke and aneurysm treatment. Penumbra's mission is to improve patient outcomes through cutting-edge technology and minimally invasive procedures.

Innovative Products

• Access Devices: Penumbra offers a range of access devices designed to facilitate the navigation and treatment of complex neurovascular anatomy.

• Stroke Revascularization: The company provides advanced solutions for the revascularization of ischemic stroke, helping to restore blood flow to the brain.

• Embolization Devices: Penumbra's embolization devices are used to treat aneurysms and other vascular abnormalities by blocking blood flow to the affected area.

Advanced Technologies

• Aspiration Systems: Penumbra's aspiration systems are designed to remove blood clots and other obstructions from the neurovascular system, improving patient outcomes in stroke treatment.

• Coil Systems: These systems are used for the embolization of aneurysms, providing a minimally invasive solution to prevent rupture and bleeding.

Global Presence and Support

• Extensive Network: Penumbra has a robust global presence, with products available in over 100 markets worldwide.

• Clinical Evidence: The company invests heavily in clinical research to support the efficacy and safety of its products, ensuring that healthcare professionals have access to the latest data and innovations.

Commitment to Quality and Innovation

Penumbra is committed to continuous innovation and quality assurance. The company's products are designed to meet the highest standards of safety and efficacy, and its manufacturing processes ensure consistent quality. Penumbra's dedication to research and development drives the creation of new and improved solutions for neurovascular conditions.